Non-invasive prenatal test EVOGEN

You pass genes to child, we provide to you information about your pregnancy.

Pregnancy for a woman is a truly amazing time, a woman blooms and becomes tender, soft and very vulnerable. She needs to take care of her health and her child health ... and we can help with that.

EVOGEN-NIPT (Non-invasive Prenatal Test "NIPT"), based on the analysis of cell-free fetal DNA of the fetus in the mother's blood by high-performance sequencing ("NGS"). A person normally has 46 chromosomes, of which 22 pairs of chromosomes are the same in men and women and 1 pair of sex chromosomes. For a man, it is X and Y, and for a woman it is XX. Technologically, NIPT could allow detecting any aneuploidy (chromosomal pathology), however, this study should be based on a number of criteria. In this regard, usually in the NIPT panel include "traditional screening chromosomal pathology", i.e. trisomies 21, 18 and 13, causing Down, Edwards and Patau syndromes and abnormalities of sex chromosomes.

NIPT is non-invasive for the fetus, does not carry the risk of its loss and provides high accuracy, which reduces the risk and the need for invasive procedures.

Non-invasive DNA test

Down syndrome

Patau syndrome

Edwards syndrome

Baby gender prediction

  • Without the use of dangerous invasive procedures
  • Requires 10 ml of blood for analysis
  • Result in just 10 working days
  • The analysis can be performed starting from the 10th week of pregnancy
  • Accuracy of non-invasive prenatal analysis exceeds 99%
  • In some cases, it is an alternative to invasive analysis

EVOGEN test allows you to determine trisomy:

  • T21 (Down syndrome)
  • T18 (Edwards syndrome)
  • T13 (Patau syndrome)

and numerical anomalies of sex chromosomes:

  • Monosomy X (MX, Turner Syndrome)
  • XXX (trisomy X)
  • XXY (Klinefelter syndrome)
  • XYY
  • Fetal sex (XX or XY) - assists in risk assessment for X-linked diseases such as hemophilia, Duchenne muscular dystrophy or congenital adrenal hyperplasia

Method limitations

  • Less than 10 (obstetric) weeks of pregnancy
  • Chromosomal abnormalities in a pregnant woman
  • Multiple pregnancy (more than 2 fetuses)
  • Malformations or markers of chromosomal abnormalities detected by ultrasound (as this may affect any other chromosome, not included in the NIPT)
  • If during the previous 3 months a pregnant woman has undergone any of the following procedures: blood transfusion, immune therapy, stem cell therapy, transplantation, radiation therapy

Limitations of existing screening methods


Chromosomal screening is currently being conducted in all developed countries, covered by national health systems.

In the Russian regions, the presence of a unified system of early combined prenatal screening of pregnant women is regulated as per the order of the Ministry of the Health (Minzdrav) of November 12, 2012. No. 572n


The method is based on ultrasound data and biochemical parameters, in this case, only indirect markers of chromosomal pathology of the fetus are estimated, because of what it has insufficient accuracy


At the same time, invasive diagnostics, providing the necessary level of reliability in regards to the risk of complications and loss of pregnancy

The confidence of a woman that her future child is well, plays an important role in carrying a pregnancy!

If you have any questions, you can get more information by filling out the feedback form:

Your name:



Your message:

Successfully sent